Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Re-evaluating cell-cycle regulation by E2Fs.

Benjamin D Rowland1, René Bernards

  • 1Division of Molecular Carcinogenesis and Center of Biomedical Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Cell
|November 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

Cancer cell·2026
Same author

The SHERPA trial: A phase I study combining SHP2 inhibitor RMC-4630 and ERK inhibitor LY3214996 in patients with KRAS-mutant pancreatic, non-small cell lung and colorectal cancer.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Exploiting immunogenic cell death to promote antitumor immunity.

Trends in immunology·2026
Same author

CLIM-TIME links genetic cancer drivers to immune landscapes.

Cell·2026
Same author

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

CRISPR knockout screens reveal JUN as the master mediator of resistance to MAPK inhibition in KRAS-mutant pancreatic cancer.

Journal of experimental & clinical cancer research : CR·2026
Same journal

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same journal

Co-option of lysosomal machinery shapes the evolution of the intracellular photosymbiosis supporting coral reefs.

Cell·2026
Same journal

LEF1 and niche factors determine T cell stemness across chronic diseases.

Cell·2026
Same journal

Recurrent patterns of TOP1-mediated neuronal genomic damage shared by major neurodegenerative disorders.

Cell·2026
Same journal

Four-dimensional molecular mapping from a spatial snapshot reveals the dynamics of hair follicle organogenesis.

Cell·2026
Same journal

Whole-cell particle-based digital twin simulations from 4D lattice light-sheet microscopy data.

Cell·2026
See all related articles

The textbook model of E2F transcription factors driving cell cycle progression is being challenged. This study proposes an alternative model for E2F function in gene regulation and DNA replication.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Genetics

Background:

  • E2F transcription factors are traditionally viewed as key regulators of the G1 to S phase cell cycle transition.
  • They are believed to activate genes necessary for DNA replication initiation.

Purpose of the Study:

  • To challenge the established model of E2F transcription factor function.
  • To present and discuss an alternative model for E2F roles in cellular processes.

Main Methods:

  • Literature review and synthesis of existing data.
  • Theoretical modeling of transcription factor activity.

Main Results:

  • Evidence suggests the traditional view of E2F function may be incomplete.

Related Experiment Videos

  • An alternative model is proposed that offers a new perspective on E2F roles.

    • Conclusions:

    • The established understanding of E2F transcription factors requires re-evaluation.
    • Alternative models are crucial for advancing our comprehension of cell cycle regulation and gene expression.